Healthcare Equipment and Supplies
Company Overview of ACell, Inc.
ACell, Inc. engages in the development and commercialization of extracellular matrix devices to repair and remodel damaged tissues and organs in a range of surgical procedures for the U.S. and international patents. It offers MatriStem technology, a non-crosslinked, resorbable, and acellular material; MatriStem Wound Care Matrix, a wound care device with regenerative medicine technology; MatriStem Plastic Surgery Matrix, a plastic surgery and wound care device; MatriStem Hernia Matrix, a general surgery device; and Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer that are wound management devices for the management of partial- and full-thickness wounds, including pressure ulcers, ve...
6640 Eli Whitney Drive
Columbia, MD 21046
Founded in 1999
Key Executives for ACell, Inc.
Chief Executive Officer and President
Vice President of Operations
Senior Vice President and General Counsel
Compensation as of Fiscal Year 2017.
ACell, Inc. Key Developments
ACell, Inc. Announces Distribution Agreement with Southmedic, Incorporated
Jan 11 17
ACell, Inc. announced a distribution agreement with Southmedic, Incorporated. Under the agreement, ACell will be the exclusive US distributor of Southmedic's Dynamic Tissue Systems (DTS) product line. Additionally, this agreement establishes Southmedic as the exclusive Canadian distributor of ACell's current line of medical devices. The DTS product portfolio includes six devices designed to facilitate faster wound closure in a variety of clinical situations. The devices provide dynamic appositional forces, or cyclic stretching, which relax the natural retraction of open wounds through mechanical stretch. Chronic cyclic stretching leads to constructive remodeling, including tissue generation and adaptation.
ACell, Inc. Appoints Sally Maher to Board of Directors
Oct 31 16
ACell, Inc. announced that Sally Maher, JD has joined the company's Board of Directors. Maher is currently Edwards Lifesciences' Vice President of Regulatory and Clinical Affairs, Critical Care. Prior to Edwards, she served as Senior Vice President, Compliance and Government Affairs, for Smith & Nephew Endoscopy. Maher will replace James Osborne on the ACell Board of Directors. Mr. Osborne will continue to advise ACell as a consultant on the current medical device reimbursement landscape. Maher has also held positions with Johnson & Johnson, Pfizer Hospital Products Groups, and the US Food and Drug Administration.
ACell, Inc. Names Brad Adams as Vice President of Sales
Aug 22 16
ACell, Inc. announced that it has named Brad Adams Vice President of Sales. He will be responsible for directing the strategy and execution of both field sales and national accounts. Adams has more than 20 years of senior healthcare management experience. Most recently, he served as Executive Vice President, Commercial for Smith & Nephew, Inc. Prior to Smith & Nephew, Adams was Vice President of Sales for Healthpoint Biotherapeutics, Inc. and previously served as Vice President of Worldwide Sales for two Johnson & Johnson companies: Animas, Inc. and Therakos, Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|